Table 6 Process and outcome indicators related with specific conditions, ACSH, prewar (1 July 2018–30 June 2019) vs. wartime (July 1, 2021– June 30, 2022)
Before war (n = 691) | During war (n = 428) | p-value | ||
|---|---|---|---|---|
Indicators | N (%) | N (%) | ||
1. Prevention of PPH | ||||
Target population: women giving birth in health care facilities | 575 (85.2) | 331 (77.34) | ||
Oxytocin use | 490 (85.2) | 225 (68.0) | < 0.001 | |
Use of any uterotonic (including oxytocin) | 528 (91.8) | 230 (69.5) | < 0.001 | |
2. Treatment of severe PPH | ||||
Target population: women with severe PPH | 166 (24.0) | 105 (24.5) | ||
Oxytocin use | 147 (88.6) | 53 (50.5) | < 0.001 | |
Ergometrine | 8 (4.8) | 0 (0.0) | 0.022 | |
Misoprostol | 144 (86.7) | 43 (41.0) | < 0.001 | |
Any of the above uterotonics | 166 (100.0) | 56 (53.3) | < 0.001 | |
Tranexamic acid | 0 (0.0) | 1 (0.3) | 0.208 | |
Removal of retained products | 44 (26.5) | 22 (23.7) | 0.299 | |
Hysterectomy | 27 (16.3) | 7 (6.7) | 0.020 | |
Proportion of cases with SMO | 84 (50.6) | 96 (91.4) | < 0.001 | |
Mortality | 3 (1.8) | 10 (9.5) | 0.003 | |
3. Anticonvulsants for eclampsia | ||||
Target population: women with eclampsia | 46 (6.7) | 33 (7.7) | ||
Magnesium sulfate | 45 (97.8) | 28 (84.9) | 0.032 | |
Other anticonvulsant | 2 (4.3) | 0 (0.0) | 0.225 | |
Any anticonvulsant | 46 (100.0) | 28 (84.9) | 0.006 | |
Proportion of cases with SMO | 33 (71.3) | 21 (63.6) | 0.445 | |
Mortality | 5 (10.9) | 7 (21.2) | 0.207 | |
4. Prevention of cesarean section-related infection | ||||
Target population: women undergoing cesarean section | 235/575 (40.9) | 137/331 (41.4) | ||
Prophylactic antibiotic during cesarean section | 213 (90.6) | 124 (90.5) | 0.968 | |
5. Treatment for sepsis | ||||
Target population: women with sepsis | 130 (18.8) | 68 (15.9) | ||
Parenteral therapeutic antibiotics | 120 (92.3) | 49 (72.1) | < 0.001 | |
Proportion of cases with SMO | 29 (22.3) | 43 (63.2) | < 0.001 | |
Mortality | 5 (3.8) | 10 (14.7) | 0.006 | |
6. Ruptured uterus | ||||
Target population: women with ruptured uterus | 22 (3.2) | 19 (4.4) | ||
Laparotomy | 22 (100.0) | 19 (100.0) | ||
Laparotomy after 3 h of hospital stay | 2 (9.0) | 9 (47.4) | 0.005 | |
Proportion of cases with SMO | 19 (86.4) | 18 (94.7) | 0.368 | |
Mortality | 1 (4.5) | 1 (5.3) | 0.915 | |
7. Preterm birth | N = 112 | N = 97 | ||
Target population: women having a preterm delivery after 3 h of hospital stay | 106 (89.1) | 90 (92.8) | 0.579 | |
Corticosteroids for fetal lung maturation | 62 (58.5) | 63 (70.0) | 0.095 | |
Early neonatal mortality | 34 (32.4) | 17 (18.9) | 0.036 | |